BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17364475)

  • 21. Molecular modeling studies of surface decoration of hemoglobin by maleimide PEG.
    Prabhakaran M; Manjula BN; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(4):381-93. PubMed ID: 16818412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation.
    Li D; Manjula BN; Acharya AS
    Protein J; 2006 Jun; 25(4):263-74. PubMed ID: 16718519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Packing density of the PEG-shell in PEG-albumins: PEGylation induced viscosity and COP are inverse correlate of packing density.
    Ananda K; Manjula BN; Meng F; Acharya VN; Intaglietta M; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):14-27. PubMed ID: 21623695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the sites of deoxyhaemoglobin PEGylation.
    Iafelice R; Cristoni S; Caccia D; Russo R; Rossi-Bernardi L; Lowe KC; Perrella M
    Biochem J; 2007 Apr; 403(1):189-96. PubMed ID: 17155933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs.
    Meng F; Tsai AG; Intaglietta M; Acharya SA
    Artif Cells Nanomed Biotechnol; 2015; 43(4):270-81. PubMed ID: 24597567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylation of Val-1(alpha) destabilizes the tetrameric structure of hemoglobin.
    Hu T; Li D; Manjula BN; Brenowitz M; Prabhakaran M; Acharya SA
    Biochemistry; 2009 Jan; 48(3):608-16. PubMed ID: 19119852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-directed PEGylation as successful approach to improve the enzyme replacement in the case of prolidase.
    Colonna C; Conti B; Perugini P; Pavanetto F; Modena T; Dorati R; Iadarola P; Genta I
    Int J Pharm; 2008 Jun; 358(1-2):230-7. PubMed ID: 18455892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells.
    Peeters L; Sanders NN; Jones A; Demeester J; De Smedt SC
    J Control Release; 2007 Aug; 121(3):208-17. PubMed ID: 17630013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEGylation of native disulfide bonds in proteins.
    Brocchini S; Balan S; Godwin A; Choi JW; Zloh M; Shaunak S
    Nat Protoc; 2006; 1(5):2241-52. PubMed ID: 17406463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune recognition of exposed xenoantigens on the surface of PEGylated bovine red blood cells.
    Gundersen SI; Kennedy MS; Palmer AF
    Biotechnol Bioeng; 2008 Oct; 101(2):337-44. PubMed ID: 18454498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation.
    Zheng C; Ma G; Su Z
    Electrophoresis; 2007 Aug; 28(16):2801-7. PubMed ID: 17702059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate.
    Hu T; Prabhakaran M; Acharya SA; Manjula BN
    Biochem J; 2005 Dec; 392(Pt 3):555-64. PubMed ID: 16111474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensive.
    Acharya SA; Friedman JM; Manjula BN; Intaglietta M; Tsai AG; Winslow RM; Malavalli A; Vandegriff K; Smith PK
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(3):239-55. PubMed ID: 16152690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering.
    Humphreys DP; Heywood SP; Henry A; Ait-Lhadj L; Antoniw P; Palframan R; Greenslade KJ; Carrington B; Reeks DG; Bowering LC; West S; Brand HA
    Protein Eng Des Sel; 2007 May; 20(5):227-34. PubMed ID: 17452434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfide bridge based PEGylation of proteins.
    Brocchini S; Godwin A; Balan S; Choi JW; Zloh M; Shaunak S
    Adv Drug Deliv Rev; 2008 Jan; 60(1):3-12. PubMed ID: 17920720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of layer-by-layer assembly of polyelectrolytes on fully functional human red blood cells in suspension for attenuated immune response.
    Mansouri S; Merhi Y; Winnik FM; Tabrizian M
    Biomacromolecules; 2011 Mar; 12(3):585-92. PubMed ID: 21306170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.
    Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ
    J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid phase pegylation of hemoglobin.
    Suo X; Zheng C; Yu P; Lu X; Ma G; Su Z
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(4):147-55. PubMed ID: 19526439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs.
    Garratty G
    Transfus Med Rev; 2004 Oct; 18(4):245-56. PubMed ID: 15497125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective modification of surface-exposed thiol groups in Trigonopsis variabilis D-amino acid oxidase using poly(ethylene glycol) maleimide and its effect on activity and stability of the enzyme.
    Slavica A; Dib I; Nidetzky B
    Biotechnol Bioeng; 2007 Jan; 96(1):9-17. PubMed ID: 16948164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.